🇺🇸 Losartan (+) amlodipine in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Acute Kidney Injury — 1 report (10%)
  2. Adverse Reaction — 1 report (10%)
  3. Chronic Kidney Disease — 1 report (10%)
  4. Dizziness — 1 report (10%)
  5. Hyperparathyroidism Secondary — 1 report (10%)
  6. Nausea — 1 report (10%)
  7. Pyrexia — 1 report (10%)
  8. Renal Failure — 1 report (10%)
  9. Staphylococcal Infection — 1 report (10%)
  10. Suicide Attempt — 1 report (10%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is Losartan (+) amlodipine approved in United States?

Losartan (+) amlodipine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Losartan (+) amlodipine in United States?

Organon and Co is the originator. The local marketing authorisation holder may differ — check the official source linked above.